Skip to main content
Journal cover image

Nonmelanoma skin cancer in inflammatory bowel disease: a review.

Publication ,  Journal Article
Long, MD; Kappelman, MD; Pipkin, CA
Published in: Inflamm Bowel Dis
June 2011

At least 1 million new cases of nonmelanoma skin cancer (NMSC) are diagnosed in the United States each year and the incidence is increasing. A higher incidence of NMSC in organ transplant recipients on immunosuppression has been documented for some time, and recent studies indicate that patients with inflammatory bowel disease (IBD), particularly those treated with immunosuppressive medications, might also be at higher risk for this condition. In this review we summarize recent data evaluating the associations between immunomodulators, antitumor necrosis factor-α biologic agents and NMSC in patients with IBD and other autoimmune conditions such as rheumatoid arthritis. We also offer recommendations for prevention of NMSC in these populations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Inflamm Bowel Dis

DOI

EISSN

1536-4844

Publication Date

June 2011

Volume

17

Issue

6

Start / End Page

1423 / 1427

Location

England

Related Subject Headings

  • Skin Neoplasms
  • Inflammatory Bowel Diseases
  • Immunosuppressive Agents
  • Immunocompromised Host
  • Humans
  • Gastroenterology & Hepatology
  • Arthritis, Rheumatoid
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Long, M. D., Kappelman, M. D., & Pipkin, C. A. (2011). Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis, 17(6), 1423–1427. https://doi.org/10.1002/ibd.21484
Long, Millie D., Michael D. Kappelman, and Clare A. Pipkin. “Nonmelanoma skin cancer in inflammatory bowel disease: a review.Inflamm Bowel Dis 17, no. 6 (June 2011): 1423–27. https://doi.org/10.1002/ibd.21484.
Long MD, Kappelman MD, Pipkin CA. Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis. 2011 Jun;17(6):1423–7.
Long, Millie D., et al. “Nonmelanoma skin cancer in inflammatory bowel disease: a review.Inflamm Bowel Dis, vol. 17, no. 6, June 2011, pp. 1423–27. Pubmed, doi:10.1002/ibd.21484.
Long MD, Kappelman MD, Pipkin CA. Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis. 2011 Jun;17(6):1423–1427.
Journal cover image

Published In

Inflamm Bowel Dis

DOI

EISSN

1536-4844

Publication Date

June 2011

Volume

17

Issue

6

Start / End Page

1423 / 1427

Location

England

Related Subject Headings

  • Skin Neoplasms
  • Inflammatory Bowel Diseases
  • Immunosuppressive Agents
  • Immunocompromised Host
  • Humans
  • Gastroenterology & Hepatology
  • Arthritis, Rheumatoid
  • 3202 Clinical sciences
  • 1103 Clinical Sciences